"The 2015 International Panel for NMO Diagnosis criteria is, as the name implies, a set of criteria used to diagnose neuromyelitis optica spectrum disorder (NMOSD) 1. They are based on a combination of clinical, laboratory, and neuroimaging findings."
"change of name from NMOS disorder to NMOS disease"
"change of name from NMOS disorder to NMOS disease"
"NMOS disease requires AQP4-IgG seropositivity"
"patients with similar clinical presentation but who are seronegative for both AQP4-IgG and MOG antibodies should be referred to as having a NMO spectrum clinical syndrome"
"IPND 2025 Criteria"
"IPND 2015 Criteria"
Expected headings
"IPND 2025 Criteria"
"IPND 2015 Criteria"
"Diagnostic criteria for NMOSD with AQP4-IgG +"
"Diagnostic criteria for NMOSD without AQP4-IgG + or NMOSD with an unknown AQP4-IgG status"
"Core clinical characteristics"
"Additional imaging (MRI) requirements for NMOSD without AQP4-IgG + and NMOSD with an unknown AQP4-IgG status"